Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) EPS (Basic) (2017 - 2020)

enVVeno Medical has reported EPS (Basic) over the past 4 years, most recently at -$2.84 for Q4 2020.

  • For Q4 2020, EPS (Basic) rose 75.83% year-over-year to -$2.84; the TTM value through Dec 2020 reached -$7.68, up 36.58%, while the annual FY2025 figure was -$33.06, 25.76% up from the prior year.
  • EPS (Basic) for Q4 2020 was -$2.84 at enVVeno Medical, down from -$1.38 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.05 in Q4 2018 and troughed at -$11.75 in Q4 2019.
  • A 4-year average of -$1.53 and a median of -$0.53 in 2017 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): surged 90.57% in 2018 and later tumbled 23400.0% in 2019.
  • Year by year, EPS (Basic) stood at -$0.53 in 2017, then surged by 90.57% to -$0.05 in 2018, then tumbled by 23400.0% to -$11.75 in 2019, then surged by 75.83% to -$2.84 in 2020.
  • Business Quant data shows EPS (Basic) for NVNO at -$2.84 in Q4 2020, -$1.38 in Q3 2020, and -$1.89 in Q2 2020.